TABLE 3.
Gabapentin (n = 207) | Placebo (n = 206) | Pa | |
---|---|---|---|
Drowsiness | .51 | ||
Mean (SD) | 1.4 (2.5) | 1.6 (2.6) | |
Concentration | .48 | ||
Mean (SD) | 1.0 (2.6) | 1.1 (2.5) | |
Diarrhea | .46 | ||
Mean (SD) | 0.5 (2.0) | 0.4 (2.0) | |
Skin irritation | .30 | ||
Mean (SD) | 0.1 (1.7) | 0.1 (1.6) | |
Swelling of hands/feet | .78 | ||
Mean (SD) | 0. 1 (1.6) | 0.0 (1.2) | |
Dry mouth | .20 | ||
Mean (SD) | 1.6 (2.4) | 1.2 (2.4) | |
Dizziness | .25 | ||
Mean (SD) | 1.3 (2.4) | 0.9 (2.1) | |
Constipation | .96 | ||
Mean (SD) | 2.0 (3.0) | 2.0 (3.0) | |
Tiredness | .11 | ||
Mean (SD) | 2.3 (3.0) | 2.8 (3.0) | |
Headache | .42 | ||
Mean (SD) | 1.3 (2.6) | 1.3 (2.5) | |
Indigestion/heartburn | .71 | ||
Mean (SD) | 2.0 (3.0) | 1.9 (2.9) | |
Anxiety/nervousness | .19 | ||
Mean (SD) | −0.8 (2.9) | −0.4 (2.9) | |
Weight gain | .45 | ||
Mean (SD) | 0.3 (1.9) | 0.1 (1.4) | |
Appetite loss | .04 | ||
Mean (SD) | 1.3 (2.7) | 1.9 (3.3) | |
Loss coordination | |||
Mean (SD) | 0.4 (1.5) | 0.4 (1.6) | .50 |
Negative mood swings | |||
Mean (SD) | 0.3 (2.2) | 0.9 (2.4) | < .01 |
Vision changes | |||
Mean (SD) | 0.7 (1.8) | 0.5 (1.3) | .96 |
Change from baseline, Positive numbers indicate improvement.
Kruskal Wallis test.